Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Recent research has shown that a new combined oral contraceptive has high efficacy, cycle control, and safety, even among a diverse American population that included women with a body mass index of 35 kg/m2. The medication contains estetrol (a novel estrogen) and drospirenone.

New Oral Contraceptive Holds Promise of Few or No Blood Clots, Other Adverse Effects

Estetrol has low effect on breast tissue